Which agents are commonly used to treat restless legs syndrome (RLS)?

Which agents are commonly used to treat restless legs syndrome (RLS)?

• A. Antidepressants and antipsychotics
• B. Dopaminergic agents and gabapentinoids
• C. Benzodiazepines and barbiturates
• D. Opioids and stimulants

Answer: (B)

Treating restless legs syndrome is most effectively done by targeting two main drug classes that address its underlying drive to move the legs: dopaminergic agents and gabapentinoids. Dopamine agonists like pramipexole or ropinirole stimulate dopamine receptors in the brain and spinal cord, which tends to reduce the urge to move and the uncomfortable sensations, especially at rest. Gabapentinoids such as gabapentin or pregabalin help calm nerve activity and can lessen sensory symptoms and improve sleep quality. Together, these two groups form the standard first-line pharmacologic approach for RLS. Other options exist, but they’re not as well aligned with the core symptoms. Antidepressants and antipsychotics can worsen RLS in many people. Benzodiazepines and barbiturates may aid sleep but don’t address the underlying symptoms and carry dependence or daytime-sedation risks. Opioids and stimulants are typically reserved for more difficult or refractory cases due to safety concerns and potential misuse.

Treating restless legs syndrome is most effectively done by targeting two main drug classes that address its underlying drive to move the legs: dopaminergic agents and gabapentinoids. Dopamine agonists like pramipexole or ropinirole stimulate dopamine receptors in the brain and spinal cord, which tends to reduce the urge to move and the uncomfortable sensations, especially at rest. Gabapentinoids such as gabapentin or pregabalin help calm nerve activity and can lessen sensory symptoms and improve sleep quality. Together, these two groups form the standard first-line pharmacologic approach for RLS.

Other options exist, but they’re not as well aligned with the core symptoms. Antidepressants and antipsychotics can worsen RLS in many people. Benzodiazepines and barbiturates may aid sleep but don’t address the underlying symptoms and carry dependence or daytime-sedation risks. Opioids and stimulants are typically reserved for more difficult or refractory cases due to safety concerns and potential misuse.